Skip to content

Perspective Therapeutics, Inc.

CATX NYSE SEC CIK 728387

Follow Perspective Therapeutics Weekly email: filings, results, news

News

2 stories filed under Perspective Therapeutics

Markets

Thread · 2 stories

Lantheus alpha therapy, CATX director, sells $131k in stock

Markets 19 d ago 3 sources also on LNTH

Perspective Therapeutics: 'Strong Buy' On Bamzireotide Navoxetan Reinforced Data And Phase 3 Plans

Markets 23 d ago

Profile

Headquarters: SEATTLE, WA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 2 stories clustered from the RSS aggregator